EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Targeting CSPG4 enhances the anti-tumor activity of CAR-NK cells for glioblastoma

Qi Xiong, Beibei Yin, Hong Jiang, Yusha Qiu, Gang Shi, Jia Xu, Tong Xu, Hongxin Deng

Cellular Oncology · 2025-10 · 48 (5) · 1539-1551

DOI: 10.1007/s13402-025-01095-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 28.07.2025. Verfasst von Qi Xiong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Ke-yuan Road 4, No. 1, Gao-p…. Hauptthemen laut MEDLINE: Glioblastoma, Killer Cells, Natural, Receptors, Chimeric Antigen, Brain Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaKiller Cells, NaturalReceptors, Chimeric AntigenBrain NeoplasmsChondroitin Sulfate ProteoglycansImmunotherapy, AdoptiveHumansAnimalsCell Line, TumorXenograft Model Antitumor AssaysMiceMembrane ProteinsChondroitin Sulfate Proteoglycan 4

Stichwörter der Autor:innen

CAR-NK cellsCSPG4Cell therapyGlioblastomaImmunotherapy

Substanzen

Receptors, Chimeric AntigenChondroitin Sulfate ProteoglycansMembrane ProteinsCSPG4 protein, humanChondroitin Sulfate Proteoglycan 4

Autor:innen und Institutionen

  • Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Ke-yuan Road 4, No. 1, Gao-peng Street, Chengdu, Sichuan, 610041, P.R. China.
  • Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Ke-yuan Road 4, No. 1, Gao-peng Street, Chengdu, Sichuan, 610041, P.R. China. denghongx@scu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University

Zitieren

APA

Xiong, Q., Yin, B., Jiang, H., Qiu, Y., Shi, G., Xu, J., Xu, T., & Deng, H. (2025). Targeting CSPG4 enhances the anti-tumor activity of CAR-NK cells for glioblastoma. Cellular Oncology, 48(5), 1539-1551. https://doi.org/10.1007/s13402-025-01095-0

Vancouver

Xiong Q, Yin B, Jiang H, Qiu Y, Shi G, Xu J, et al. Targeting CSPG4 enhances the anti-tumor activity of CAR-NK cells for glioblastoma. Cellular Oncology. 2025;48(5):1539-1551. doi:10.1007/s13402-025-01095-0

BibTeX
@article{Xiong2025,
  author = {Xiong, Qi and Yin, Beibei and Jiang, Hong and Qiu, Yusha and Shi, Gang and Xu, Jia and Xu, Tong and Deng, Hongxin},
  title = {Targeting CSPG4 enhances the anti-tumor activity of CAR-NK cells for glioblastoma},
  journal = {Cellular Oncology},
  year = {2025},
  volume = {48},
  number = {5},
  pages = {1539--1551},
  doi = {10.1007/s13402-025-01095-0}
}
Kostenlos starten →